We are live on ! Find out more
EYPT icon

EyePoint Inc

85 hedge funds and large institutions have $238M invested in EyePoint Inc in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $813K | Put options by funds: $204K

17% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 24

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

1% more funds holding

Funds holding: 8485 (+1)

0% more capital invested

Capital invested by funds: $238M → $238M (+$371K)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.36% less ownership

Funds ownership: 88.7%88.34% (-0.36%)

Holders
85
Holders Change
+1
Holders Change %
+1.19%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
28
Reduced
24
Closed
8
Calls
$813K
Puts
$204K
Net Calls
+$609K
Net Calls Change
-$583K

EYPT Hedge Fund Activity: Q3 2022 in Review

85 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in EyePoint Inc (EYPT) for Q3 2022, worth a combined $238M — up 0.16% from $238M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new EYPT positions and 8 closed out — a net gain of 1 holder — while 28 added to existing stakes and 24 trimmed.

The largest buyer was OrbiMed, adding an estimated $7.03M. The largest seller was Point72 Asset Management, cutting an estimated $6.78M.

  • 85 institutional investors held EyePoint Inc (EYPT) as of Q3 2022, up from 84 in Q2 2022.
  • Funds reported $238M of EyePoint Inc stock for Q3 2022, up 0.16% quarter-over-quarter.
  • 9 funds opened new EyePoint Inc positions in Q3 2022 and 8 closed out, a net change of +1 holder.
  • The largest EyePoint Inc buyer in Q3 2022 was OrbiMed, an estimated $7.03M added.
  • The largest EyePoint Inc seller in Q3 2022 was Point72 Asset Management, an estimated $6.78M sold.

Based on aggregated 13F filings for Q3 2022.